[Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
D000328:Adult; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects; D003013:Clostridium / Q000187:drug effects; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005243:Feces / Q000382:microbiology; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006801:Humans; D007422:Intestines / Q000187:drug effects / Q000382:microbiology*; D007778:Lactobacillus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D013291:Streptococcus / Q000187:drug effects; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors; D014295:Trimethoprim / Q000008:administration & dosage / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Einfluss des Kombinationspräparates Trimethoprim-Sulfamethoxazol bei kurzfristiger und langfristiger Applikation auf die Darmflora des Menschen.